Tom Branna, Editorial Director03.28.21
Milan-based cosmetics contract manufacturer Intercos has signed an agreement with nearby University of Milano-Bicocca to conduct research on sustainable formulations and processes to develop innovative beauty products. The initial, shared investment is valued at more than one million euros (about $1.14 million).
Under terms of the five-year deal, Intercos and UMB will share a lab, researchers and tech equipment at the Vedano al Lambro campus, a 20-minute drive from Intercos headquarters.
“Since the very beginning of this company, we understood that research and innovation was the only way to grow. We wanted to be the company that could invest more money, energy and workforce in innovation in the world of cosmetics globally, and we managed to do that,” said Dario Ferrari, founder and president, Intercos.
For the University, the collaboration may provide key learnings that help the institution improve its courses to match the real demands of the industry.
“Cosmetics are often considered the ‘poor relatives’ of pharmaceuticals but there’s a lot of people applying for this industry because it has been making progress in leaps and bounds and it moves faster than pharmaceutical. We move in a more agile way, which is rooted in the nature of our business itself, so we can bring a way of thinking that’s innovative and faster,” Ferrari said.
Under terms of the five-year deal, Intercos and UMB will share a lab, researchers and tech equipment at the Vedano al Lambro campus, a 20-minute drive from Intercos headquarters.
“Since the very beginning of this company, we understood that research and innovation was the only way to grow. We wanted to be the company that could invest more money, energy and workforce in innovation in the world of cosmetics globally, and we managed to do that,” said Dario Ferrari, founder and president, Intercos.
For the University, the collaboration may provide key learnings that help the institution improve its courses to match the real demands of the industry.
“Cosmetics are often considered the ‘poor relatives’ of pharmaceuticals but there’s a lot of people applying for this industry because it has been making progress in leaps and bounds and it moves faster than pharmaceutical. We move in a more agile way, which is rooted in the nature of our business itself, so we can bring a way of thinking that’s innovative and faster,” Ferrari said.